Fineotex Chemical Q2 FY27 Results Board Meet Set November 13

Fineotex Chemical Limited will consider its Q2 FY27 results at a board meeting on November 13, following Q1 net sales of Rs 376.63 crore and profit for the year of Rs 48.21 crore. The September-quarter numbers will show whether the sharp expansion seen in the June quarter has continued after the CrudeChem Technology acquisition.

When will Fineotex Chemical report Q2 FY27 results?

Fineotex Chemical has scheduled a board meeting on November 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company disclosed the meeting schedule on November 5, while its trading window remains closed.

The formal results were not available in the information under discussion as of the announcement. This distinction matters because posts and result previews circulated before the company filing do not provide reported September-quarter revenue, profit or margins. Under the earlier timeline, November 14 was the statutory outer deadline for publishing September-quarter results, but Fineotex Chemical has now provided a specific board-meeting date.

What will happen after the Q2 FY27 board meeting?

Fineotex Chemical has scheduled a virtual earnings conference call for November 16, 2026, at 11:00 AM IST, to discuss Q2 and H1 FY27 operational and financial performance. The call is expected to include the Executive Director, CFO, CEO, and the Head of M&A and Investor Relations.

For shareholders, the call is the next planned opportunity for management commentary after the filing. The discussion may clarify the operational trend behind the reported numbers, including progress in the US oilfield chemicals business. It can also provide context on capacity use and the revenue outlook cited by management, although the scheduled call itself does not establish any financial outcome for Q2.

What did Fineotex Chemical report in Q1 FY27?

Fineotex Chemical reported net sales turnover of Rs 376.63 crore, total income of Rs 386.72 crore and profit for the year of Rs 48.21 crore in the quarter ended June 2026. Net sales were Rs 313.73 crore in March 2026 and Rs 137.07 crore in June 2025, while profit for the year was Rs 43.79 crore and Rs 25.03 crore respectively.

The June-quarter figures marked a substantial change from the revenue range reported across the June, September and December 2025 quarters. Revenue had been between roughly Rs 137 crore and Rs 184 crore in those periods before rising to Rs 313.73 crore in March 2026 and Rs 376.63 crore in June 2026. Context shared around the results attributed the shift to consolidation of CrudeChem Technology, a US oil and gas specialty chemicals business.

Which Q2 FY27 figures should investors monitor?

Investors should monitor whether Fineotex Chemical sustains the higher revenue base established in Q1, along with the movement in operating profit, EBITDA and profit for the year. The Q1 figures included operating profit of Rs 59.14 crore, EBITDA of Rs 69.23 crore and EBIT of Rs 64.84 crore, providing the immediate reference point for the September-quarter release.

The year-on-year comparison will also be closely watched. The available September 2025 base was revenue of about Rs 138 crore and profit of about Rs 26 crore. However, comparisons need to be read alongside the change in the business following CrudeChem Technology's consolidation, rather than treated as a like-for-like operating comparison without company disclosures.

Does Fineotex Chemical have a verified Q2 earnings forecast?

No verified analyst estimate for Fineotex Chemical's Q2 FY27 revenue or profit was included in the available context. Some social-media discussions anticipated a good quarter, while other material explicitly said that no quarterly earnings forecast data was available.

That absence makes the exchange filing more important than numerical expectations circulating ahead of the event. Management had previously confirmed 63% capacity utilisation at the Texas facility and reiterated guidance for USD 100 million in US revenue for FY27. Investors can assess any management update against those disclosed operational markers, but should not treat unverified price targets or earnings projections as company guidance.

Conclusion

Fineotex Chemical enters its Q2 FY27 result event after a June quarter in which net sales reached Rs 376.63 crore and profit for the year reached Rs 48.21 crore. The core issue for the September-quarter release is whether the company has maintained the larger post-acquisition business scale while preserving the profitability shown in Q1.

The next disclosed milestones are the November 13 board meeting and the November 16 earnings call. Investors should watch the filed standalone and consolidated numbers, management's comments on the US oilfield chemicals business, Texas capacity utilisation, and any update to the stated USD 100 million US revenue guidance for FY27.